“The Not-So-Standard Model: Reconsidering Agency-Head Review of Administrative Adjudication Decisions”
- Administrative Law
Administrative Law Review
2023
“New Innovation Models in Medical AI”
Washington University Law Review
2022
“Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act”
- Intellectual Property and Antitrust
New York University Journal of Intellectual Property and Entertainment Law
2021
“Cannabis for Medical Use: FDA and DEA Regulation in the Hall of Mirrors”
- Health Law
Food and Drug Law Journal
2019
“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”
- Intellectual Property and Antitrust
Iowa Law Review
2019
“Opting Into Device Regulation in the Face of Uncertain Patentability”
- Intellectual Property and Antitrust
- Law and Technology
Marquette Intellectual Property Law Review
2019
“Shifting Institutional Roles in Biomedical Innovation in a Learning Healthcare System”
- Law and Technology
- Health Law
Journal of International Economics
2018
Daedalus
2018
“Promoting Healthcare Innovation on the Demand Side”
- Intellectual Property and Antitrust
- Law and Technology
Journal of Law and the Biosciences
2017
Science
2017
“Diagnostics Need Not Apply”
- Intellectual Property and Antitrust
- Law and Technology
Boston University Journal of Science & Technology Law
2015
“Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents”
- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2015
“Prometheus Rebound: Diagnostics, Nature, and Mathematical Algorithms”
- Intellectual Property and Antitrust
Yale Law Journal Online
2013
“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”
- Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012
“Patent Costs and Unlicensed Use of Patented Inventions”
- Intellectual Property and Antitrust
University of Chicago Law Review
2011
Lewis and Clark Law Review
2008
“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”
- Intellectual Property and Antitrust
Houston Law Review
2008
“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”
- Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007
Michigan Telecommunications and Technology Law Review
2007
“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”
- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006
Nature Biotechnology
2006
Industrial and Corporate Change
2006
New England Journal of Medicine
2005
Yale Journal of Health Policy, Law, and Ethics
2005
Journal of Institutional and Theoretical Economics
2004
“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”
- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004
Comptes rendus Biologies
2003
Science
2003
“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”
- Intellectual Property and Antitrust
Fordham Law Review
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
- Intellectual Property and Antitrust
Law and Contemporary Problems
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
- Intellectual Property and Antitrust
American Scientist
2003
American Journal of Bioethics
2002
“Public vs. Proprietary Science: A Fruitful Tension?”
- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002
Academic Medicine: Journal of the Association of American Medical Colleges
2002
“Public vs. Proprietary Science: A Fruitful Tension?”
- Intellectual Property and Antitrust
Daedalus
2002
“The Shifting Functional Balance of Patents and Drug Regulation”
- Intellectual Property and Antitrust
Health Affairs
2001
“Analyze This: A Law and Economics Agenda for the Patent System”
- Intellectual Property and Antitrust
Vanderbilt Law Review
2000
“Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences”
- Intellectual Property and Antitrust
Emory Law Journal
2000
Nature Reviews Genetics
2000
“The Promise and Perils of Strategic Publication to Create Prior Art: A Response to Professor Parchomovsky”
- Intellectual Property and Antitrust
Michigan Law Review
2000
“National Policy Perspectives-Streamlining the Transfer of Research Tools”
- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
1999
“Can Patents Deter Innovation? The Anticommons on Biomedical Research”
- Intellectual Property and Antitrust
Science
1998
Law Quadrangle Notes
1998
Trends in Genetics
1998
“Focus on Faculty - Rebecca S. Eisenberg”
Law Quadrangle Notes
1998
Nature Genetics
1997
“Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research”
- Intellectual Property and Antitrust
Virginia Law Review
1996
“Intellectual Property at the Public-Private Divide: The Case of Large-Scale cDNA Sequencing”
- Intellectual Property and Antitrust
University of Chicago Law School Roundtable
1996
Trends in Biotechnology
1996
“Opinion Letter as to the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences”
- Intellectual Property and Antitrust
AIPLA Quarterly Journal
1995